| 注册
首页|期刊导航|中国实验方剂学杂志|基于PI3K/Akt信号通路探讨麻黄连翘赤小豆汤改善肥胖型多囊卵巢综合征大鼠的机制

基于PI3K/Akt信号通路探讨麻黄连翘赤小豆汤改善肥胖型多囊卵巢综合征大鼠的机制

胡诗维 赵敏 朱璧然 张金融 阮璐瑶 旷吉 华江环 刘哲 姚妍玥 王济

中国实验方剂学杂志2026,Vol.32Issue(8):21-31,11.
中国实验方剂学杂志2026,Vol.32Issue(8):21-31,11.DOI:10.13422/j.cnki.syfjx.20252109

基于PI3K/Akt信号通路探讨麻黄连翘赤小豆汤改善肥胖型多囊卵巢综合征大鼠的机制

Mechanisms of Mahuang Lianqiao Chixiaodoutang in Improving Obesity-type Polycystic Ovary Syndrome in Rats Based on PI3K/Akt Signaling Pathway

胡诗维 1赵敏 1朱璧然 1张金融 1阮璐瑶 1旷吉 1华江环 1刘哲 1姚妍玥 2王济3

作者信息

  • 1. 湖北中医药大学基础医学院,武汉 430065
  • 2. 湖北中医药大学中医学院,武汉 430065
  • 3. 北京中医药大学国家中医体质与治未病研究院,北京 100029
  • 折叠

摘要

Abstract

Objective:To investigate the mechanisms by which Mahuang Lianqiao Chixiaodoutang(MLC)improves obesity-type polycystic ovary syndrome(PCOS)through the phosphatidylinositol 3-kinase(PI3K)/protein kinase B(Akt)signaling pathway.Methods:Thirty-six female Sprague-Dawley(SD)rats were randomly divided into a blank control group(Con)and an obesity-type PCOS model preparation group.The model was induced by gavage with letrozole(1 mg·kg-1)combined with a high-fat diet(HFD).After model establishment,the obesity-type PCOS model preparation group was further divided into the model group(Mod,normal saline),metformin group(Met,0.3 g·kg-1),low-dose MLC group(MLC-L,4.3 g·kg-1),medium-dose MLC group(MLC-M,8.6 g·kg-1),and high-dose MLC group(MLC-H,17.2 g·kg-1).Active components of MLC and targets of obesity-type PCOS were screened from databases,a protein-protein interaction(PPI)network was constructed,and gene ontology(GO)and Kyoto Encyclopedia of Genes and Genomes(KEGG)pathway enrichment analysis was performed.The gut microbiota structure was analyzed based on 16S rRNA sequencing and correlated with network pharmacology pathways.Body weight and estrous cycle were dynamically monitored.Ovarian morphology was observed by hematoxylin-eosin(HE)staining.Cell apoptosis was detected by terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling(TUNEL).Enzyme-linked immunosorbent assay(ELISA)was used to detect levels of follicle-stimulating hormone(FSH),luteinizing hormone(LH),anti-Müllerian hormone(AMH),testosterone(T),and estradiol(E2).Western blot was used to detect the protein expression levels of phosphorylated PI3K/PI3K(p-PI3K/PI3K),phosphorylated Akt/Akt(p-Akt/Akt),B-cell lymphoma-2(Bcl-2),and Bcl-2-associated X protein(Bax).Results:Network pharmacology screening identified 124 active components of MLC and 408 overlapping targets between the herbal formula and the disease.Core targets such as Akt1 and Bcl-2 were revealed.As indicated by 16S rRNA sequencing,the abundances of Lachnospiraceae,Lachnoclostridium,and Dorea were increased in the MLC groups(P<0.05),while the abundance of Veillonella was decreased(P<0.05).KEGG correlation analysis integrating network pharmacology and gut microbiota data showed significant enrichment of the PI3K/Akt signaling pathway.Animal experiments showed that,compared with the Mod group,body weight decreased to normal levels in the Met,MLC-M,and MLC-H groups.The estrous cycle became regular.The number of corpora lutea increased and cystic follicles decreased.Serum levels of T,FSH,and LH/FSH were reduced(P<0.05,P<0.01),while the E2 level was increased(P<0.01).Ovarian cell apoptosis was reduced(P<0.01),and the protein expression levels of p-PI3K/PI3K,p-Akt/Akt,and Bcl-2 in ovarian tissue were significantly increased,whereas Bax protein expression was significantly decreased(P<0.05,P<0.01).Conclusion:MLC can regulate gut microbiota structure,effectively improve ovarian pathology in rats with obesity-type PCOS,and inhibit ovarian granulosa cell apoptosis.The mechanism may be associated with upregulation of the PI3K/Akt signaling pathway.

关键词

麻黄连翘赤小豆汤/肥胖型多囊卵巢综合征(PCOS)/磷脂酰肌醇3-激酶(PI3K)/蛋白激酶B(Akt)信号通路/肠道菌群

Key words

Mahuang Lianqiao Chixiaodoutang/obesity-type polycystic ovary syndrome(PCOS)/phosphatidylinositol 3-kinase(PI3K)/protein kinase B(Akt)signaling pathway/gut microbiota

分类

医药卫生

引用本文复制引用

胡诗维,赵敏,朱璧然,张金融,阮璐瑶,旷吉,华江环,刘哲,姚妍玥,王济..基于PI3K/Akt信号通路探讨麻黄连翘赤小豆汤改善肥胖型多囊卵巢综合征大鼠的机制[J].中国实验方剂学杂志,2026,32(8):21-31,11.

基金项目

湖北省自然科学基金创新发展联合基金项目(2023AFD114) (2023AFD114)

中国实验方剂学杂志

1005-9903

访问量0
|
下载量0
段落导航相关论文